Free Trial

OraSure Technologies (OSUR) Competitors

OraSure Technologies logo
$3.85 -0.14 (-3.51%)
(As of 11/15/2024 ET)

OSUR vs. CERS, ANIK, UTMD, TCMD, KIDS, CRY, ATRI, WST, COO, and ALGN

Should you be buying OraSure Technologies stock or one of its competitors? The main competitors of OraSure Technologies include Cerus (CERS), Anika Therapeutics (ANIK), Utah Medical Products (UTMD), Tactile Systems Technology (TCMD), OrthoPediatrics (KIDS), CryoLife (CRY), Atrion (ATRI), West Pharmaceutical Services (WST), Cooper Companies (COO), and Align Technology (ALGN). These companies are all part of the "medical" sector.

OraSure Technologies vs.

OraSure Technologies (NASDAQ:OSUR) and Cerus (NASDAQ:CERS) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, analyst recommendations, community ranking, valuation, dividends, risk and institutional ownership.

93.5% of OraSure Technologies shares are held by institutional investors. Comparatively, 78.4% of Cerus shares are held by institutional investors. 3.4% of OraSure Technologies shares are held by company insiders. Comparatively, 3.4% of Cerus shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

OraSure Technologies has a net margin of 5.07% compared to Cerus' net margin of -11.19%. OraSure Technologies' return on equity of 3.55% beat Cerus' return on equity.

Company Net Margins Return on Equity Return on Assets
OraSure Technologies5.07% 3.55% 3.23%
Cerus -11.19%-37.90%-10.35%

Cerus received 19 more outperform votes than OraSure Technologies when rated by MarketBeat users. Likewise, 72.30% of users gave Cerus an outperform vote while only 69.53% of users gave OraSure Technologies an outperform vote.

CompanyUnderperformOutperform
OraSure TechnologiesOutperform Votes
550
69.53%
Underperform Votes
241
30.47%
CerusOutperform Votes
569
72.30%
Underperform Votes
218
27.70%

OraSure Technologies has a beta of 0.05, suggesting that its stock price is 95% less volatile than the S&P 500. Comparatively, Cerus has a beta of 1.2, suggesting that its stock price is 20% more volatile than the S&P 500.

In the previous week, Cerus had 1 more articles in the media than OraSure Technologies. MarketBeat recorded 3 mentions for Cerus and 2 mentions for OraSure Technologies. OraSure Technologies' average media sentiment score of 0.94 beat Cerus' score of 0.81 indicating that OraSure Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
OraSure Technologies
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cerus
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

OraSure Technologies has higher revenue and earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than OraSure Technologies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OraSure Technologies$405.47M0.71$53.65M$0.1525.67
Cerus$176.23M1.81-$37.49M-$0.11-15.64

OraSure Technologies presently has a consensus target price of $6.67, indicating a potential upside of 73.16%. Cerus has a consensus target price of $3.63, indicating a potential upside of 110.76%. Given Cerus' stronger consensus rating and higher probable upside, analysts clearly believe Cerus is more favorable than OraSure Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OraSure Technologies
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Cerus
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

Summary

OraSure Technologies and Cerus tied by winning 9 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OSUR vs. The Competition

MetricOraSure TechnologiesSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$287.17M$4.56B$5.07B$8.66B
Dividend YieldN/A39.56%5.10%4.06%
P/E Ratio25.6725.28101.9217.46
Price / Sales0.7155.021,196.9569.07
Price / Cash3.0251.7441.0436.36
Price / Book0.675.486.345.87
Net Income$53.65M$13.76M$119.64M$225.66M
7 Day Performance-10.26%-6.52%-5.13%-1.34%
1 Month Performance-5.41%2.19%-2.72%1.15%
1 Year Performance-46.08%50.62%31.10%24.02%

OraSure Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OSUR
OraSure Technologies
4.6184 of 5 stars
$3.85
-3.5%
$6.67
+73.2%
-44.2%$287.17M$405.47M25.67638
CERS
Cerus
2.8499 of 5 stars
$1.72
-4.4%
N/A-0.6%$319.42M$156.37M-15.64625Short Interest ↑
ANIK
Anika Therapeutics
3.8926 of 5 stars
$17.25
+1.5%
N/A-17.6%$252.71M$166.66M-2.59357High Trading Volume
UTMD
Utah Medical Products
3.3408 of 5 stars
$66.05
-0.7%
N/A-22.2%$223.91M$50.22M15.47180Positive News
TCMD
Tactile Systems Technology
3.7905 of 5 stars
$15.66
+0.2%
N/A+37.5%$375.84M$274.42M24.09980
KIDS
OrthoPediatrics
4.2291 of 5 stars
$22.93
+1.1%
N/A-26.1%$555.37M$148.73M-18.64200
CRY
CryoLife
1.3047 of 5 stars
N/AN/AN/A$703.22M$253.23M596.201,200
ATRI
Atrion
N/A$459.92
flat
N/AN/A$809.46M$181.60M43.23720Analyst Forecast
WST
West Pharmaceutical Services
4.9796 of 5 stars
$314.49
-7.0%
N/A-8.6%$22.78B$2.88B46.6610,600Analyst Revision
Positive News
COO
Cooper Companies
3.5067 of 5 stars
$99.63
-0.2%
N/A+17.0%$19.84B$3.59B55.5015,000Analyst Upgrade
Short Interest ↑
News Coverage
ALGN
Align Technology
4.692 of 5 stars
$223.69
+0.9%
N/A+10.1%$16.70B$3.96B38.1721,610

Related Companies and Tools


This page (NASDAQ:OSUR) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners